Julius Keyl

8PUBLICATIONS
68CO-AUTHORS
Haematological tumoursContext learningImage processingPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 05, 2026
Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal Cancer.

Julius Keyl, René Hosch, Fabian Hörst

|Sep 08, 2025
Neural interaction explainable AI predicts drug response across cancers.

Philipp Keyl, Julius Keyl, Andreas Mock

Pageof 2